Home / Learn / Oncology Pharmacy / Advisory Committee

Advisory Committee

Olalekan Ajayi, PharmD, MBA
Director of Practice Transformation
Sheridan Memorial Hospital
Sheridan, WY

Olalekan “Lekan” Ajayi, PharmD, MBA, is oncology service line manager at Sheridan Memorial Hospital in Sheridan, Wyoming. In this role, Dr. Ajayi oversees both strategic and operational initiatives of the oncology and internal medicine programs. He has also worked extensively as a clinical pharmacist and an oncology pharmacy manager for eight years.

Dr. Ajayi currently serves on the ACCC Board of Trustees and has worked on a number of ACCC initiatives.

He is passionate about patient access to quality cancer care in rural communities. Specifically, Dr. Ajayi is interested in expanding patient access to oncology clinical trials and is working with ACCC on ways to overcome the challenges of patient accruals for clinical trials in rural cancer programs.

He holds a Doctor of Pharmacy degree from the University of Wyoming, and a Master’s in Business Administration from the University of Colorado, Denver.

Zinkeng Asonganyi
Zinkeng Asonganyi, PharmD
System Director of Ambulatory Pharmacy Services
University of Texas Medical Branch
Houston, TX

Dr. Zinkeng Asonganyi (aka “Dr Z”) oversees all facets of ambulatory practice at the University of Texas Medical Branch, including retail and specialty pharmacy services, outpatient infusion, and the integration of pharmacists into ambulatory clinics. Prior to this role, Dr. Asonganyi served as the senior pharmacy manager at Anne Arundel Medical Center (Luminis Health) in Annapolis, Maryland, overseeing the oncology department, investigational drug services, and outpatient pharmacy operations, including the development of a specialty pharmacy business. Dr. Asonganyi is an active participant in the American Society of Health System Pharmacists (ASHP) and several local pharmacy organizations.

Dr. Asonganyi is a 2012 graduate of the University of Findlay College of Pharmacy in Ohio, and he has been a health system pharmacy administrator for most of his career. He is passionate about controlling pharmaceutical expenses through supply chain and formulary management as well as revenue cycle management for both medical and pharmacy benefits.

Melody Chang
Melody Chang, RPh, MBA, BCOP
Director of Pharmacy Operations
Florida Cancer Specialists & Research Institute
Fort Myers, Florida
Melody Chang, RPh, MBA, BCOP, is the director of pharmacy operations for the Florida Cancer Specialists and for the American Oncology Network. She provides strategic leadership and direction to over 100 clinics with clinical and business perspectives. In her role, she assists on drug procurement, develops drug utilization and formulary initiatives that ensure cost-effectiveness and optimized therapeutic outcomes.

In addition, Melody provides guidance on pharmacy clean-room design, ensuring that the pharmacy is in compliance with regulatory requirements. 

Melody currently serves as pharmacist liaison to the Florida Society of Clinical Oncology (FLASCO) Board of Directors.

Danielle Duy
Danielle Duy, BA, CPhT
Pharmacy Access Specialist
SSM Health Cancer Care
St. Louis, MO

Danielle Duy has 30 years of pharmacy experience. She worked more than two decades as a Pharmacy Technician in retail and long-term care pharmacies. Currently, Ms. Duy holds the position of Pharmacy Access Specialist at SSM Health Cancer Care. As a Pharmacy Access Specialist at SSM, Ms. Duy helps patients navigate financial barriers to acquire medications. Her special interests include improving workflows, patient experience, and customer service. She is active in the Association of Community Cancer Centers Financial Advocacy Network.

 

Jorge Garcia
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Assistant Vice President - System Oncology Pharmacy Services, Non-Oncology Infusion Center Pharmacy Services
Miami Cancer Institute, Baptist Health South Florida
Miami, Florida

Jorge J. García, PharmD, MS, MHA, MBA, FACHE, serves as an assistant vice president at Baptist Health South Florida with responsibility for system-wide oncology pharmacy services primarily at the Miami Cancer Institute, the Lynn Cancer Institute, and inpatient oncology pharmacy services at several acute hospitals. Dr. García has pioneered pharmacy charge integrity and revenue management in the health-system setting and is a thought leader and national speaker in this area, as well as in the areas of alternative payment models, biosimilars, and value-based oncology care. Dr. García leads advocacy efforts at the national level to promote evaluation of safe and effective use of biosimilars, along with stakeholder engagement to support a more just and sustainable biosimilar pharmacoeconomics model.   

Dr. García obtained his Doctor of Pharmacy and MBA from Nova Southeastern University in 2010. He then transitioned to the University of Pittsburgh Medical Center to pursue an ASHP-accredited PGY-1 & PGY-2 Health-System Pharmacy Administration Residency and a Master of Science in Pharmacy Administration. He also completed an MHA from Florida Atlantic University. Dr. García is a board member at the Florida Society of Clinical Oncology (FLASCO), a recipient of the FLASCO 2018 Above and Beyond Award, and a fellow of the American College of Healthcare Executives. 

Emily Hajjar
Emily Hajjar, PharmD, MS, BCPS, BCACP, BCGP
Professor, Program Director Population Health Pharmacy Program
Thomas Jefferson University Hospitals
Philadelphia, PA

Dr. Hajjar serves as the program director for the Jefferson College of Pharmacy Population Health Pharmacy program. She also provides clinical services to the Jefferson Family and Community Medicine Senior Center Practice and the Kimmel Cancer Center Senior Adult Oncology and Outpatient Supportive Care clinics. Dr. Hajjar has published a variety of peer-reviewed publications and textbook chapters on polypharmacy in elderly patients and geriatric pharmacotherapy issues. She is a past recipient of the Jefferson College of Pharmacy AACP Teacher of the Year Award, Dean’s Faculty Achievement Award, and the Thomas Jefferson University Lindback Distinguished Teaching Award.

Dr. Hajjar earned her PharmD at Duquesne University and then completed a pharmacy practice residency at the University of Rochester Medical Center in New York. She went on to complete a geriatric pharmacy specialty residency at the Minneapolis Veteran’s Affairs Medical Center, followed by a geriatric pharmacotherapy-epidemiology fellowship at the University of Minnesota College of Pharmacy.

Kirollos-Hanna-100x100
Kirollos Hanna, PharmD, BCPS, BCOP
Assistant Professor of Pharmacy
Hematology/Oncology Clinical Pharmacist
Mayo Clinic College of Medicine
Rochester, MN

Kirollos Hanna, PharmD, BCPS, BCOP, is assistant professor of pharmacy at the Mayo Clinic College of Medicine, and primarily practices hematology/oncology pharmacy at the University of Minnesota Medical Center and Mayo Clinic.

Dr. Hanna is a nationally recognized expert in genitourinary cancers, multiple myeloma, and chronic leukemias. His research interests focus on outcome measures for patients with rare diseases. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, American Journal of Health-System Pharmacy, Journal of Oncology Pharmacy Practice, and Journal of Hematology Oncology Pharmacy. He is a member of the 2018 inaugural 40 Under 40 Rising Stars and Emerging Leaders in Cancer class. He is also an active member of the Patient-Centered Outcomes Research Institute, Aplastic Anemia & MDS International Foundation, and the American College of Clinical Pharmacy.

On a national level, Dr. Hanna serves on the executive council for the National Oncology Community Dispensing Association (NCODA) and as president for the Southern Affiliate Chapter of the Minnesota Society of Health-System Pharmacists (MSHP). He is an active member and has been an invited speaker for NCODA, Hematology/Oncology Pharmacy Association, MSHP, among others and has been featured on The Video Journal of Oncology and Specialty Pharmacy Times.

Dr. Hanna received his Doctor of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital in Nashville, Tennessee, and his oncology residency at St. Luke's Mountain States Tumor Institute in Boise, Idaho.

Mara Hofherr
Mara Hofherr, PharmD
Oncology Clinical Pharmacist
Delbert Day Cancer Institute
St Louis, MO
 
Mahta Mahmoudieh
Mahta Mahmoudieh, PharmD
Pharmacy Clinical Specialist, Hematology/Oncology
University of Arizona - Banner Health
Tucson, AZ
 
Sandeep Parsad
Sandeep Parsad, PharmD, MBA, BCOP
Assistant Pharmacy Director, Cancer & Investigational Drug Services;
Director, PGY2 Oncology Pharmacy Residency Program
University of Chicago Medicine
Chicago, Illinois

Sandeep Parsad, PharmD, MBA, BCOP, is the assistant director of pharmacy at the University of Chicago Medicine. She is the director of the PGY2 oncology pharmacy residency program, co-chair of the Oncology Drug Safety Committee, and oversees hematology/oncology and investigational drug services. 

Dr. Parsad has a strong interest in stem cell transplantation, hematologic malignancies, value-based payment models, and oncology quality initiatives.

Daniel Zlott Headshot
Daniel Zlott, PharmD, BCOP
Senior Vice President of Education and Business Development,
American Pharmacists Association
Washington, DC
Daniel Zlott, PharmD, BCOP is the Senior Vice President of Education and Business Development at the American Pharmacists Association. Prior to joining APhA he worked as a Clinical Pharmacy Specialist with the U.S. National Cancer Institute’s Immunotherapy, Surgery, Endocrine Oncology, and Thoracic/GI Malignancy Branches at the U.S. National Institutes of Health (NIH). He was part of the team that developed the first Chimeric Antigen Receptor T-cell therapy given to treat B-cell cancers. He was also the Director of the NIH PGY2 Oncology Pharmacy Residency Program and a clinical investigator on more than 40 NCI-sponsored clinical trials, examining new and innovative ways to treat cancer. Dr. Zlott has served two terms on the Board of Trustees of the American Pharmacists Association, and has also chaired numerous committees with the Hematology/Oncology Pharmacy Association.  He is a graduate of the University of California San Francisco and completed his PGY1 Pharmacy Practice Residency there before moving to the NIH, where he completed his PGY2 Oncology Pharmacy Residency.